Synapse - Joachim Yahalom

Results (43)

Langerhans cell histiocytosis in adults is associated with increased hematologic and solid malignancies

Meeting Abstract

Ma, J.; Laird, J.; Chau, K.; Chelius, M.; Bell, A. C.; Zhang, Z.; Lok, B. H.; Yahalom, J.
Hematological Oncology (2017)

A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma

Meeting Abstract

Kumar, A.; Casulo, C.; Advani, R.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Chen, R.; Constine, L. S.; Courtien, A. I.; Dandapani, S. V.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save

Dose and/or volume reduction using consolidation volume radiation therapy (CVRT) lowers dose to heart and lungs in early-stage Hodgkin lymphoma patients with bulky disease

Meeting Abstract

Yang, J. C.; Kumar, A.; Chapman, K. L.; Burleson, S.; Huang, C.; Constine, L. S.; Hoppe, R. T.; Dandapani, S.; Straus, D. J.; Moskowitz, C. H.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save

Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE

Meeting Abstract

Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save

Outcome of curative radiotherapy for localised follicular lymphoma in the era of (18)F-FDG PET-CT staging: An internal collaborative study on behalf of ILROG

Meeting Abstract

Brady, J. L.; Binkley, M. S.; Hajj, C.; Chelius, M. R.; Chau, K. W.; Levis, M.; Choi, S.; Suh, C.; Hardy, S. J.; Constine, L. S.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save

Disparities in survival by insurance status in patients with Hodgkin lymphoma

Journal Article

Parikh, R. R.; Grossbard, M. L.; Green, B. L.; Harrison, L. B.; Yahalom, J.
Cancer (2015)

Fulltext@MSK | Save

Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy

Journal Article

Gandikota, N.; Hartridge-Lambert, S.; Migliacci, J. C.; Yahalom, J.; Portlock, C. S.; Schöder, H.
Cancer (2015)

Fulltext@MSK | Save

Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy

Journal Article

Ekenel, M.; Iwamoto, F. M.; Ben Porat, L. S.; Panageas, K. S.; Yahalom, J.; Deangelis, L. M.; Abrey, L. E.
Cancer (2008)

Fulltext@MSK | Save

Primary bone lymphoma: Treatment results and prognostic factors with long-term follow-up of 82 patients

Journal Article

Beal, K.; Allen, L.; Yahalom, J.
Cancer (2006)

Fulltext@MSK | Save

Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low‐grade and intermediate‐grade non‐Hodgkin lymphoma: Results of a prospective randomized study

Journal Article

Yahalom, J.; Varsos, G.; Fuks, Z.; Myers, J.; Clarkson, B. D.; Straus, D. J.
Cancer (1993)

Fulltext@MSK | Save